Modulation of SUMO proteins by 17β-estradiol in the mitochondria of breast cancer

摘要

1. The breast cancer cell lines MCF-7 and MDA-MB-231 exhibit major differences in their mitochondrial proteomic profiles. 2. The key players of the SUMOylation pathway were identified across breast cancer cell line treatment groups.